NL-OMON43237撤回不适用
*Effects of Butyrate on Intestinal permeability & inflammation, Intellectual performance, Immune activation and systemic Inflammation in renal disease. - B4I-study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •For the haemodialysis group:
- •- Haemodialysis patients, stable on dialysis for >6 months ;For the post renal transplantation group:
- •- Functional renal allograft, 6-24 months post transplantation;Furthermore: age 40-70, non-smoking, BMI between 20 and 30.
排除标准
- •- Diabetics
- •- Antibiotic treatment within the last 3 months
- •- Probiotic use
- •- Chronic diarrhoea or fulfilling the criteria for irritable bowel syndrome
- •- Irritable bowel disorder or other comorbidity that might affect the intestinal flora
- •- Dysphagia
- •- Active infection (CMV, EBV)
研究者
相似试验
招募中
不适用
Effects of a butyrate enema on systemic concentrations of short chain fatty acidslivermetastasispancreascarcinoma1001793410019654NL-OMON32250niversiteit Maastricht20
已完成
不适用
Mode of Action of Butyrate in the Human ColonIrritable Bowel Syndrome (IBS)HealthyNCT05249023Örebro University, Sweden37
已完成
不适用
Effects of Butyrate on Colonic Health of Patients With Diarrhoea Predominant IBS and UC in RemissionGut HealthNCT00696098Maastricht University Medical Center80
已完成
不适用
Effects of Butyrate Enemas on Colonic HealthHealthyNCT00693355Maastricht University Medical Center16
已完成
不适用
Evaluation of Butyrate and Palmitoylethanolamide in IBS Patients (B/P3_1)Irritable Bowel Syndrome With DiarrheaNCT06432569University of Padova50